GLP-1 Price Vietnam: Ozempic, Mounjaro, and Retatrutide Compared

How Much Does Ozempic Cost in Vietnam?

Ozempic in Vietnam costs 3.5 to 6 million VND ($140 to $240) per month through the hospital and clinic route, and 1.5 to 2.5 million VND ($60 to $100) per month as research-grade semaglutide, the same molecule in a different regulatory category.

Those ranges come straight from our semaglutide Vietnam guide, which also lists a middle channel: a private doctor source at 3 to 4 million VND ($120 to $160) per month. For context, the same guide puts the US cash price at $900 to $1,100 per month without insurance, so even the premium clinic route here lands at roughly a quarter of American pricing. The brand-level picture, including pharmacy availability, is in the Ozempic Vietnam guide, and the higher-dose weight-loss brand is covered separately in the Wegovy Vietnam guide.

The wide spread between the clinic price and the research-grade price is the whole story of this page. You are not comparing two products so much as two systems: one buys medical supervision and a registered brand, the other buys the molecule alone and puts the verification work on you. The molecule itself, what semaglutide is and how it works, has its own compound profile.

What Does Mounjaro Cost in Vietnam?

There is no registered Mounjaro price in Vietnam, and the reason is regulatory rather than commercial. Dr. Nguyen Van Loi, head of drug registration at the Drug Administration of Vietnam, told domestic press on 10 July 2026 that Mounjaro has not been granted a Vietnamese marketing authorisation certificate, and that products in that position are not eligible for legal import or circulation in Vietnam. No registered hospital or pharmacy route exists for the branded pen, so there is no registered supply to price. Vietnam publishes declared wholesale prices only for registered medicines, which means a drug with no registration has no declared price to look up. That is a registration position, not a temporary stock gap.

So the useful question about any Mounjaro figure you are quoted is which channel it came from, not whether it sounds high or low. That is the position stated on our Mounjaro Vietnam guide, and this page will not invent a number the source page declines to publish. What the site does publish is a figure for the research-grade route, which is the route that actually exists here: the tirzepatide Vietnam guide puts it at 1.5 to 3 million VND per month ($60 to $120), and the community supply index lists one supplier at 4,700,000 VND (about $185). Read those as research-route figures, not pharmacy prices.

At the top of the research range tirzepatide runs above semaglutide; on the pharmacy channel there is no tirzepatide figure to compare, because it holds no registration. The pharmacology behind that positioning, and whether the premium is justified for a given person, is a prescriber question; the compound-level comparison is in tirzepatide vs semaglutide.

What Does Retatrutide Cost in Vietnam?

Retatrutide has no pharmacy price anywhere, Vietnam included, because it is still in clinical trials with no approved version sold in any country; in Vietnam it is available only as a research-grade compound.

Our retatrutide Vietnam guide states that the total cost, shipping included, sits well below what a month of branded GLP-1 medication costs in the US. For a concrete anchor, the community supply index lists retatrutide at 5,200,000 VND (about $205), and the same figure carries into the GLP-1 overview comparison table. The listing states no quantity, so it is not a monthly cost, and that is why this page does not rank retatrutide by month against the other two compounds.

Because every retatrutide source is research-grade by definition, there is no regulated channel to fall back on. That makes supplier vetting and independent testing the entire quality question, which is also the comparison made in retatrutide vs tirzepatide.

How Do GLP-1 Prices in Vietnam Compare Side by Side?

Semaglutide is the cheapest of the three on both routes, tirzepatide sits above it on the research route, and retatrutide exists only on the research route, carried as a single supply listing with no quantity stated:

Two figures in the research column come from the community supply listings rather than a per-month range, and the table says so in the cell, because quoting a supplier listing as a monthly cost would be inventing a number. Where a page on this site publishes a range, we quote the range. Where it publishes a single listing, we quote the listing. Nothing here is extrapolated.

What Is the Difference Between the Hospital Route and the Research-Grade Route?

The hospital route buys a registered brand, a consultation, and medical supervision at a premium; the research-grade route buys the same molecule without the supervision, at a fraction of the price, and shifts the burden of verification onto the buyer.

Neither route is automatically right or wrong. The clinic premium pays for a doctor who can screen for contraindications and manage side effects, which matters if you have underlying conditions. The research route exists because the price gap is large and consistent supply matters to people paying out of pocket, but it sits outside the pharmacy framework, so the legal and quality context is on you to understand. Our guide on how to buy peptides in Vietnam covers the sourcing side, the supply index shows how the research market is organised, and peptide legality in Vietnam explains the regulatory frame both routes sit inside.

The price comparison on this page only means something once you have picked a route. Comparing a hospital Ozempic quote to a research-grade semaglutide listing is comparing two different products with two different risk profiles, not two prices for one thing.

Why Is a Too-Cheap GLP-1 Price a Red Flag?

A price far below every published range is the single most common signal of a counterfeit, underdosed, or diverted product, because genuine supply has a floor cost that no honest seller can undercut by half. The red flags that travel with a bait price:

This is not a theoretical risk. The World Health Organization issued a medical product alert in 2024 for falsified Ozempic found inside regulated supply chains, and the US FDA has repeatedly warned about counterfeit Ozempic seized outside the authorized chain. The full playbook for this market is in our guides to spotting a fake GLP-1 in Vietnam and counterfeit Ozempic in Vietnam.

How Do You Compare GLP-1 Prices Safely?

You compare GLP-1 prices safely by fixing the compound and route first, converting every quote to one unit, and verifying the product behind the price before the price means anything:

Step four is where most comparisons fail, and it has its own guides: how to verify a peptide COA walks through the four checks, our explainer on why a COA matters makes the broader case, and the testing labs directory lists independent labs that will test the vial you actually received. The buyer verification checklist ties the whole process together.

Frequently Asked Questions

References

Note on sourcing: every price range on this page is quoted from a named page on this site and cited to it, and prices move with supply, so confirm any figure at the point of purchase. The Vietnamese regulatory references above are the basis for the registration and declared-price position on Mounjaro; the WHO and FDA references document the falsified-GLP-1 risk that makes a too-cheap price a red flag. Neither set is the basis for any price figure.